Half Year 2024 Biocon Ltd Earnings Call Transcript
Good evening, everyone. I'm Saurabh Paliwal from Biocon Investor Relations team, and I would like to welcome you to Biocon's earnings call for Q2 FY '24.
(Operator Instructions)
Please note that the chat box is disabled, but you can raise any technical concerns by sending us an e-mail to [email protected].
I would like to bring to your attention that this conference call is being recorded. The recording will be made available on the website within a day, and the transcript will be made available subsequently.
Today to discuss this quarter's business performance and future outlook for the company, we have Dr. Kiran Mazumdar-Shaw, our Executive Chairperson; Mr. Peter Bains, Group CEO, Mr. Siddharth Mittal, MD and CEO of Biocon Limited; Mr. Shreehas Tambe, MD and CEO of Biocon Biologics; along with other senior management colleagues across our business segments.
Before we begin, I would like to point out to everyone the safe harbor related to today's call. Comments made during this call may be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |